Legal and ethical issues of newborn screening

Rahul K Dhanda1, Philip R Reilly

  • 1Bioethics Program, Interleukin Genetics, 135 Beaver St., Waltham, MA 02452, USA.

Pediatric Annals
|August 29, 2003
PubMed

Insights

Newborn screening involves complex ethical and legal issues, including genetic testing and resource allocation. Despite challenges, its successful implementation offers valuable lessons for related healthcare technologies.

Area of Science:

  • Medical Ethics
  • Public Health Policy
  • Genetic Screening

Background:

  • Newborn screening programs present multifaceted ethical and legal challenges.
  • These include bioethical considerations common to genetic testing and informed consent.
  • Classical medical ethics questions regarding resource allocation are also pertinent.

Purpose of the Study:

  • To analyze the ethical and legal landscape of newborn screening.
  • To identify areas for improvement in technical, ethical, and legal aspects.
  • To highlight lessons learned from successful implementation for future technologies.

Main Methods:

  • Review of ethical and legal concerns in newborn screening.
  • Analysis of societal integration and stakeholder perspectives.
  • Case study approach on implementation successes.

Main Results:

  • Newborn screening faces ethical dilemmas in genetic testing, informed consent, and resource allocation.
  • The mandatory, state-based intervention, while not fully integrated, has faced less resistance than anticipated.
  • Significant room for technical, ethical, and legal improvements exists.

Conclusions:

  • Despite challenges, newborn screening offers valuable implementation lessons.
  • Policymakers, physicians, and scientists should leverage successful aspects for related technologies.
  • Continuous improvement in technical, ethical, and legal frameworks is essential for maximizing program potential.

Related Concept Videos

What is Genetic Engineering?00:49

What is Genetic Engineering?

Overview
CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
Ethics in Research01:56

Ethics in Research

Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Psychosurgery01:30

Psychosurgery

Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...